NCT02742506 (MUSICOREVEIL) is a NA clinical trial of Electroencephalography (EEG) in Coma, sponsored by Hospices Civils de Lyon.

Who is sponsoring NCT02742506?

NCT02742506 is sponsored by Hospices Civils de Lyon.

What drugs are being tested in NCT02742506?

Interventions in NCT02742506: Electroencephalography (EEG).

Is NCT02742506 still recruiting?

NCT02742506 is currently completed. Last updated 3 September 2025.

Last reviewed 2025-09-03 · How we verify

NCT02742506: MUSICOREVEIL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Beneficial Effects of Music on Cognition and Consciousness Level

Completed NA Last updated 3 September 2025

What this trial tests

NA trial testing Electroencephalography (EEG) in Coma in 86 participants. Completed in 23 October 2019.

Timeline

25 June 2013

Primary endpoint
23 October 2019

23 October 2019

Quick facts

Lead sponsor	Hospices Civils de Lyon
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	86
Start date	25 June 2013
Primary completion	23 October 2019
Estimated completion	23 October 2019
Sites	1 location across France

Drugs / interventions tested

Electroencephalography (EEG)

Conditions studied

Coma — all drugs for Coma →

Sponsor

Hospices Civils de Lyon — full company profile →

Who can join

Adults 18 to 80, any sex, with Coma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Exposure to music improves cognitive function in 'healthy' participants and in brain-damaged patients. However, it is still difficult to understand what precisely in music causes a positive effect : are they emotional components, familiarity or preference which improve cognition or is there any specific effect of music? Moreover, it is not yet possible to characterize the neural and functional links between the brain systems solicited by music and those associated with other cognitive functions enhanced by music. Finally, researches on brain-damaged patients have not exploited the potential effect of music on the level of alert and perceptual awareness, while this type of stimulation could be a valuable tool to improve cognition in patients with a disturbance of consciousness and alertness. The main objective is to describe the impact of music on the brain's response to self-referential or neutral stimuli in brain-damaged patients with persistent consciousness disorder after a coma and in healthy participants.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Twenty-four-hour rhythmicities in disorders of consciousness are associated with a favourable outcome.
Gobert F, Corneyllie A, Bastuji H, Berthomier C, et al · · 2023 · cited 5× · PMID 38030756 · DOI 10.1038/s42003-023-05588-2

Verify or expand the search:

Other trials of Electroencephalography (EEG)

Trials testing the same drug.

NCT07455682 — Auditory Processing in DOC Patients · not yet recruiting
NCT07110493 — Study of Visual Perception Phenomena: Phosphene Mapping Induced by TMS and Its Relationship With Eye Movements · NA · recruiting
NCT06867549 — Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Stage II · Phase 2 · recruiting
NCT06813937 — Peripheral Magnetic Stimulation (PMS) Effects on Somatosensory Perception in Patients with Upper Limb Amputation · NA · recruiting
NCT05905705 — Disruptions of Brain Networks and Sleep by Electroconvulsive Therapy · recruiting

Other recruiting trials for Coma

Currently open trials in the same condition.

NCT07247669 — Evaluation and Optimization of Telephone Triage Using Artificial Intelligence (AI) Models for the Detection of Demands f · active not recruiting
NCT06265168 — Comprehensive Observations and Multidisciplinary Approaches in the Management of Unconscious Patients · active not recruiting
NCT07020091 — Predicting Mortality in Patients With Return of Spontaneous Circulation After Cardiac Arrest · active not recruiting
NCT05321459 — Predictive Outcome in Comatose Patients · recruiting
NCT05861323 — Feasibility of the Comfort Measures Only Time Out (CMOT) · NA · active not recruiting

Other Hospices Civils de Lyon trials

Trials by the same sponsor.

NCT07569536 — Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock · Phase 3 · not yet recruiting
NCT07529314 — Evaluating Interventional Radiology for Cancer Pain Management · NA · not yet recruiting
NCT07273929 — Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device · Phase 3 · not yet recruiting
NCT07474532 — Attitudes and Beliefs Related to Benzodiazepine Deprescribing · not yet recruiting
NCT07313007 — Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02742506 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospices Civils de Lyon
Last refreshed: 3 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02742506.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing